David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.33% |
| 2 | Technology | 14.87% |
| 3 | Consumer Discretionary | 9.92% |
| 4 | Healthcare | 7.34% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FL
2726
CALL
DELISTED
Foot Locker
FL
| $2.37M | ﹤0.01% |
52,000
| – | – |
|
2727
Prothena Corp
PRTA
$467M
| $2.37M | ﹤0.01% |
33,321
+13,026
| +64% | +$809K |
|
2728
Iron Mountain
IRM
$36.5B
| $2.37M | ﹤0.01% |
+54,566
| New | +$2.46M |
|
2729
CALL
ArcelorMittal
MT
$56.3B
| $2.37M | ﹤0.01% |
78,500
| – | – |
|
|
GNAC
2730
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
| $2.37M | ﹤0.01% |
243,035
+16,294
| +7% | +$158K |
|
2731
Markel Group
MKL
$22.4B
| $2.37M | ﹤0.01% |
1,980
-2,153
| -52% | -$2.65M |
|
2732
Babcock & Wilcox
BW
$1.14B
| $2.36M | ﹤0.01% |
368,341
+296,315
| +411% | +$2.07M |
|
|
IRBT
2733
DELISTED
iRobot
IRBT
| $2.36M | ﹤0.01% |
30,054
+7,211
| +32% | +$614K |
|
2734
CALL
Louisiana-Pacific
LPX
$4.94B
| $2.36M | ﹤0.01% |
38,400
| – | – |
|
2735
PUT
Upbound Group
UPBD
$1.12B
| $2.34M | ﹤0.01% |
41,700
-41,300
| -50% | -$2.43M |
|
|
PSAG
2736
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
| $2.34M | ﹤0.01% |
241,619
+116,619
| +93% | +$1.12M |
|
2737
CALL
National Beverage
FIZZ
$3.04B
| $2.34M | ﹤0.01% |
44,600
| – | – |
|
2738
PUT
HealthEquity
HQY
$7.81B
| $2.34M | ﹤0.01% |
+36,100
| New | +$2.51M |
|
2739
Sonoco
SON
$5.61B
| $2.34M | ﹤0.01% |
39,238
+5,555
| +16% | +$355K |
|
2740
iShares Core MSCI Emerging Markets ETF
IEMG
$162B
| $2.34M | ﹤0.01% |
37,840
| – | – |
|
|
GTH
2741
DELISTED
Genetron Holdings Limited ADS
GTH
| $2.34M | ﹤0.01% |
56,248
+6,064
| +12% | +$279K |
|
2742
Maximus
MMS
$3.12B
| $2.33M | ﹤0.01% |
28,019
+23,355
| +501% | +$2M |
|
2743
PUT
Inspire Medical Systems
INSP
$1.76B
| $2.33M | ﹤0.01% |
10,000
| – | – |
|
2744
PUT
Pultegroup
PHM
$24.1B
| $2.33M | ﹤0.01% |
50,700
+33,700
| +198% | +$1.75M |
|
2745
CALL
Bio-Techne
TECH
$11.4B
| $2.33M | ﹤0.01% |
19,200
-62,400
| -76% | -$7.59M |
|
2746
PDF Solutions
PDFS
$1.95B
| $2.33M | ﹤0.01% |
100,918
-59,554
| -37% | -$1.23M |
|
2747
PUT
GrowGeneration
GRWG
$97.8M
| $2.32M | ﹤0.01% |
94,200
+9,400
| +11% | +$332K |
|
2748
CALL
Newmont
NEM
$139B
| $2.32M | ﹤0.01% |
+42,700
| New | +$2.52M |
|
2749
Ecopetrol
EC
$34B
| $2.32M | ﹤0.01% |
161,514
-254,357
| -61% | -$3.45M |
|
2750
Lam Research
LRCX
$399B
| $2.31M | ﹤0.01% |
40,660
-94,840
| -70% | -$5.77M |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.